MARINUS PHARMACEUTICALS
Marinus Pharmaceuticals is a clinical-stage biopharmaceutical company dedicated to the development and commercialization of ganaxolone, offering a new mechanism of action with safe and convenient dosing, for adult and pediatric patient populations in acute and chronic care settings. The company was founded in 2003 and is based in Branford, Connecticut.
MARINUS PHARMACEUTICALS
Industry:
Biopharma Biotechnology Health Diagnostics Pharmaceutical Therapeutics
Founded:
2003-01-01
Address:
Branford, Connecticut, United States
Country:
United States
Website Url:
http://www.marinuspharma.com
Total Employee:
101+
Status:
Active
Contact:
484-253-6792
Email Addresses:
[email protected]
Total Funding:
314.37 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Google Tag Manager WordPress Content Delivery Network
Current Advisors List
Current Employees Featured
Founder
Stock Details
Investors List
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Debt - Marinus Pharmaceuticals
Oaktree Capital Management
Oaktree Capital Management investment in Post-IPO Debt - Marinus Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Marinus Pharmaceuticals
Bain Capital Life Sciences
Bain Capital Life Sciences investment in Post-IPO Equity - Marinus Pharmaceuticals
Canaan Partners
Canaan Partners investment in Series C - Marinus Pharmaceuticals
Domain Associates
Domain Associates investment in Series C - Marinus Pharmaceuticals
Foundation Medical Partners
Foundation Medical Partners investment in Series C - Marinus Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series C - Marinus Pharmaceuticals
RMI Partners
RMI Partners investment in Venture Round - Marinus Pharmaceuticals
Sofinnova Investments
Sofinnova Investments investment in Series B - Marinus Pharmaceuticals
Key Employee Changes
| Date | New article |
|---|---|
| 2020-06-15 | Marinus Pharmaceuticals Appoints Martha Manning as Vice President, General Counsel and Secretary |
Official Site Inspections
http://www.marinuspharma.com Semrush global rank: 3.75 M Semrush visits lastest month: 3.6 K
- Host name: 192.86.185.35.bc.googleusercontent.com
- IP address: 35.185.86.192
- Location: United States
- Latitude: 38.6583
- Longitude: -77.2481
- Timezone: America/New_York
More informations about "Marinus Pharmaceuticals"
Home - Marinus Pharmaceuticals
Marinus Pharmaceuticals is a clinical stage biopharmaceutical company dedicated to the development of ganaxolone, offering a new mechanism of action with demonstrated safety …See details»
Ethics & Compliance - Marinus Pharmaceuticals
At Marinus, we are committed to our patients, physicians, and epilepsy community, as we plan our path forward to providing much needed options for patients living with seizure disorders. We …See details»
Patients - Marinus Pharmaceuticals
We collaborate with patient advocacy organizations to increase awareness and education, promote earlier diagnosis, advance new therapies, better understand the patients we serve, …See details»
Marinus Pharma - LinkedIn
Marinus Pharmaceuticals, Inc. is a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders. Program management and R&D leader with 25 years of...See details»
Marinus Pharmaceuticals - Crunchbase Company …
Marinus Pharmaceuticals reformulates, develops, and commercializes drugs to treat neurological, psychiatric, and pain disorders. Marinus Pharmaceuticals experienced a significant decline in its market value, losing 80% in one day …See details»
Marinus Pharmaceuticals Inc | Life Sciences PA - Default Site
Marinus is a specialty pharmaceutical company dedicated to the reformulation, development, and commercialization of ganaxolone, the most advanced neurosteroid in development. …See details»
Scott Braunstein - CEO & Director at Marinus Pharma | The Org
Scott Braunstein was appointed Chief Executive Officer of Marinus in August 2019, executive chairman in February 2019 and has served on our Board since September 2018. Dr. …See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Appoints …
Nov 17, 2022 · Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat seizure disorders, announced …See details»
Marinus Pharma: Culture - LinkedIn
Our dedicated team of professionals, scientists, and medical experts strive to demonstrate the value of ganaxolone as a potential first-in-class, fast-acting, safe, and innovative therapy for...See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Unveils …
Feb 23, 2021 · RADNOR, Pa.-- (BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics …See details»
About Marinus - Marinus Pharmaceuticals
Marinus is committed to improving the lives of patients with seizure disorders through the development of innovative treatment options and by closely collaborating with patients, …See details»
Marinus Pharmaceuticals Unveils New Brand as the Company …
Feb 23, 2021 · RADNOR, Pa.-- ( BUSINESS WIRE )-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics …See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Provides ...
Aug 10, 2021 · Marinus completed the first ever Phase 3 pivotal trial in children with CDKL5 deficiency disorder last year and is conducting a Phase 2 trial in tuberous sclerosis complex …See details»
Marinus Pharma Information - RocketReach
Marinus Pharma is a Pharmaceutical Manufacturing, Pharmaceuticals, and Biotechnology company located in Radnor, Pennsylvania with $27.7 million in revenue and 173 employees. …See details»
Join Our Team - Marinus Pharmaceuticals
At Marinus, we are committed to making a meaningful difference in the lives of patients and families with seizure disorders. Come join us! Our culture is underpinned by our guiding …See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Bolsters ...
Apr 12, 2021 · RADNOR, Pa.-- (BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics …See details»
Overview, News & Similar companies - ZoomInfo.com
Jul 9, 2024 · View Marinus Pharmaceuticals (www.marinuspharma.com) location in Pennsylvania, United States , revenue, industry and description. Find related and similar companies as well …See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Provides ...
May 17, 2021 · RADNOR, Pa.-- (BUSINESS WIRE)-- Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics …See details»
Marinus Pharmaceuticals, Inc. - Marinus Pharmaceuticals Provides ...
Aug 13, 2024 · RADNOR, Pa.-- (BUSINESS WIRE)-- Marinus Pharmaceuticals , Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics …See details»
Our Medicine - Marinus Pharmaceuticals
Our Medicine Product information is for U.S. residents only. Prescribing Information: English Spanish Medication Guide: English Spanish ZTALMY Patient Website ZTALMY Healthcare …See details»